Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenqing Qi
Institution:
St. Jude Children's Research Hospital
Observed institution:
St. Jude Children's Research Hospital
ORCID:
0000-0002-0135-843X
Observed ORCID:
0000-0002-0135-843X
OpenAlex ID:
A5083030029
Recent Advances in c-Jun N-Terminal Kinase (JNK) Inhibitors
2020
·
Gang Li
, Wenqing Qi
, et al.
·
Current Medicinal Chemistry
·
50
Genomic profiling identifies genes and pathways dysregulated by HEY1–NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis
2022
·
Wenqing Qi
, Wojciech Rosikiewicz
, et al.
·
The Journal of Pathology
·
27
PDF
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
2024
·
Melvin E. Thomas
, Wenqing Qi
, et al.
·
Leukemia
·
9
PDF
Oncogenic Potential and Sensitivity to Menin Inhibitors of a Novel Fusion KAT6B::NUTM2B in Congenital Myeloid Sarcoma with Bone Marrow Involvement
2024
·
Rebecca Voss
, Wenqing Qi
, et al.
·
Blood
·
1
PDF
Novel KAT6B::NUTM2B fusion oncogene in congenital acute myeloid leukemia and implications for menin inhibitor therapy
2026
·
Rebecca K. Voss
, Wenqing Qi
, et al.
·
Haematologica
PDF
Abstract 3359: HEY1::NCOA2 fusion disturbs the transcriptional program of chondrogenic differentiation and activates oncogenes in mesenchymal chondrosarcoma tumorigenesis
2024
·
Wenqing Qi
, Wojciech Rosikiewicz
, et al.
·
Cancer Research
Abstract LB200: Pdgf/Pi3k/akt axis activation by hey1-ncoa2 fusion and potential target in the treatment of mesenchymal chondrosarcoma
2022
·
Wenqing Qi
, Lu Wang
·
Cancer Research
Abstract LB188: RNA-seq and chIP-seq profiling identifies genes and pathways dysregulated by hey1-ncoa2 fusion and shed a light on mesenchymal chondrosarcoma tumorigenesis
2021
·
Wenqing Qi
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
87
H-index:
3
I10-index:
2
Year
Topic
Type